Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

10:10 AM ET Form 4
Insider Selling Global-E Online Ltd. GLBE

Global-E Online President Nir Debbi Sells $630K of Stock

Nir Debbi, President, sold 14,582 shares of Global-E Online Ltd. at $42.31 to $43.80 a share (average $43.22) in 3 transactions, worth $630K in total on Nov 2, 2026. Shares held after the trade: 4,342,793 (-0.0%).

Value
$630K
Shares
14,582
Average price
$43.22
Role
President
Holding change
-0.0%
Trade date
Nov 2, 2026
10:03 AM ET 10-Q
Financial Results City Holding Co CHCO

City Holding Q3 2026 Results: Net Income $34.6M, Down 1.6% YoY

City Holding Company reported net income of $99.6 million for the first nine months of 2026, a slight increase from $98.9 million in the prior year period. While net interest income grew to $183.0 million, the company experienced a significant increase in accumulated other comprehensive loss due to $72.1 million in unrealized losses on available-for-sale securities.

Key figure
Net income $34.6M · -1.6% YoY
10:02 AM ET 10-Q
Financial Results Seres Therapeutics, Inc. MCRB

Seres Therapeutics Q3 2026 Results: Net Loss of $16.3M

Seres Therapeutics is a clinical-stage company that has identified conditions raising substantial doubt about its ability to continue as a going concern. The company reported 10,195,031 shares of common stock outstanding as of November 2, 2026, and is seeking additional funding or strategic partnerships to advance its SER-155 clinical programs.

Key figure
Net loss $16.3M
9:44 AM ET 10-Q
Financial Results Ocugen, Inc. OCGN ▶ Call

Ocugen Q3 2026 Results: Net Loss of $3.6M, Loss Narrows

Ocugen, Inc. reported total assets of $108.1 million as of September 30, 2026, a significant increase from $43.5 million at the end of 2025, primarily driven by $59.6 million in new short-term investments. The company is currently advancing its Phase 3 trial for OCU400 and Phase 2/3 trial for OCU410ST while maintaining its status as a non-accelerated filer and smaller reporting company.

Key figure
Net loss $3.6M
9:39 AM ET 10-Q
Financial Results Avis Budget Group, Inc. CAR

Avis Budget Group Q3 2026 Results: Net Income $183M, Down 49.0% YoY

Avis Budget Group, Inc. reported its third quarter 2026 results, noting a common stock outstanding count of 35,337,823 shares as of October 28, 2026. The filing highlights significant risks including high competition in the mobility industry, volatility in travel demand, and potential impacts from ongoing military conflicts and inflationary pressures on fleet costs.

Key figure
Net income $183M · -49.0% YoY
9:39 AM ET 8-K
Financial Results Essential Utilities, Inc. WTRG

Essential Utilities Financial Results

Essential Utilities reported Q3 2026 GAAP net income of $103.8 million ($0.36 per share) on revenues of $508.3 million, driven by regulatory recoveries and customer growth. The company reaffirmed its infrastructure investment target of $1.7 billion for 2026 and provided an update on its pending merger with American Water, which is now expected to close in Q1 2027.

Counterparty
American Water

“Our strong performance this quarter highlights the consistent earnings growth generated by both our water and natural gas divisions. These results demonstrate our team’s dedication to operational excellence and strategic infrastructure investment. As we work toward closing our merger with American Water in Q1 2027, we remain focused on the meaningful benefits our combined organization can bring to the communities we serve and to our shareholders.”

Christopher Franklin, Chairman and Chief Executive Officer
9:37 AM ET 8-K
Clinical Trial Data Oncolytics Biotech Inc ONCY

Oncolytics Biotech Clinical Trial Data

Oncolytics Biotech announced translational data from an ongoing Phase 1/2 study of pelareorep in combination with a checkpoint inhibitor for squamous cell anal cancer (SCAC). The data showed that the treatment more than doubled immune activation levels in nearly all patients and expanded HPV-16-specific T cell clones, which was associated with tumor shrinkage and objective responses.

9:29 AM ET 8-K
Leadership Change Flowers Foods Inc FLO

Flowers Foods Leadership Change

Flowers Foods, Inc. has elected Shaun P. Mara and Ken A. Plunk to its board of directors, effective November 18, 2026. Both individuals will serve on the Audit and Finance Committees, and their election increases the total board size to ten members.

9:28 AM ET 10-Q
Financial Results Innospec Inc. IOSP

Innospec Q3 2026 Results: Net Income $31.8M, Up 146.5% YoY

Innospec Inc. reported net sales of $473.6 million for the third quarter of 2026, up from $441.9 million in the prior year, with net income attributable to the company rising to $31.8 million. For the first nine months of 2026, operating income increased significantly to $117.9 million compared to $82.7 million in 2025, largely due to the absence of asset impairment charges that occurred in the previous year.

Key figure
Net income $31.8M · +146.5% YoY
9:27 AM ET 10-Q
Financial Results Westlake Corp WLK ▶ Call

Westlake Q3 2026 Results: Turns Profitable, Net Income $6M

Westlake Corporation reported net sales of $8,904 million for the first nine months of 2026, showing growth over the prior year. The company returned to profitability with a net income of $132 million compared to a significant net loss in 2025, which was primarily driven by a $727 million goodwill impairment charge.

Key figure
Net income $6M
9:26 AM ET 8-K
M&A Deal Shoals Technologies Group, Inc. SHLS

Shoals Technologies Group M&A Deal with Array Technologies, Inc.

Shoals Technologies Group entered into a definitive merger agreement to be acquired by Array Technologies in an all-stock transaction. Shoals shareholders will receive 1.6931 shares of Array common stock for each Shoals share, resulting in Shoals shareholders owning approximately 65% of the combined energy infrastructure company.

Counterparty
Array Technologies, Inc.
9:26 AM ET 8-K
Business Update Cencora, Inc. COR

Cencora Business Update

Cencora, Inc. announced a reorganization of its operating model and reporting structure to advance growth priorities and improve visibility. Beginning in fiscal 2027, the company will report results across three segments: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The filing includes supplemental unaudited historical segment data for fiscal 2025 and 2026 recast under this new structure to assist investor analysis.

9:21 AM ET 8-K
Loan & Debt Clarivate PLC CLVT

Clarivate $500M Debt Financing with Clarivate Science Holdings Corporation

Clarivate Plc's subsidiary, Clarivate Science Holdings Corporation, has launched cash tender offers to repurchase up to $500 million in aggregate principal amount of its outstanding 3.875% Senior Secured Notes due 2028 and 4.875% Senior Notes due 2029. The offers include specific series caps of $400 million for the 2028 notes and $100 million for the 2029 notes, aimed at managing the company's debt profile.

Value
$500M
Counterparty
Clarivate Science Holdings Corporation
9:20 AM ET 10-Q
Financial Results JELD-WEN Holding, Inc. JELD

JELD-WEN Holding Q3 2026 Results: Net Loss of $17.2M, Loss Narrows

JELD-WEN Holding, Inc. filed its Form 10-Q for the quarter ended September 26, 2026, reporting 86,774,941 shares of common stock outstanding. The filing outlines significant restructuring activities, the divestiture of its former Australasia business, and updates to its senior unsecured notes including a $350 million issuance maturing in 2032.

Key figure
Net loss $17.2M
9:19 AM ET 8-K
Investor Presentation Labcorp Holdings Inc. LH

Labcorp Holdings Investor Presentation

Labcorp Holdings Inc. announced that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026. The event will feature a fireside chat and a live audio webcast will be available through the company's investor relations website.

9:19 AM ET 10-Q
Financial Results Equator Beverage Co MOJO

Equator Beverage Q3 2026 Results: Turns Profitable, Net Income $123K

EQUATOR Beverage Co reported a significant increase in net income to $1,298,872 for the nine months ended September 30, 2026, compared to $176,087 in the prior year, driven by revenue growth and a $638,942 income tax benefit. The company's total stockholders' equity improved to $1,985,310 from $555,973 at the end of 2025, while total liabilities decreased following the repayment of related party loans.

Key figure
Net income $123K
9:18 AM ET 10-Q
Financial Results UroGen Pharma Ltd. URGN

UroGen Pharma Q3 2026 Results: Net Loss of $1.46M, Loss Narrows

UroGen Pharma Ltd. reported Q3 2026 results featuring revenue from Jelmyto and Zusduri. The company significantly restructured its debt in early 2026, including a $100 million loan agreement with Pharmakon and the classification of $11.2 million in prepaid forward obligations as current liabilities.

Key figure
Net loss $1.46M
9:18 AM ET 10-Q
Financial Results SelectQuote, Inc. SLQT ▶ Call

SelectQuote Q1 2026 Results: Net Loss of $20.3M, Loss Narrows

SelectQuote reported a net loss of $20.3 million for the quarter ended September 30, 2026, an improvement from the $30.5 million loss in the prior year. Total revenue decreased to $280.0 million from $328.8 million, driven by declines in both pharmacy and commission-based services.

Key figure
Net loss $20.3M
9:18 AM ET 8-K
Clinical Trial Data Cullinan Therapeutics, Inc. CGEM

Cullinan Therapeutics Clinical Trial Data

Cullinan Therapeutics released updated Phase 1 dose escalation data for CLN-049 in patients with relapsed or refractory AML and MDS, showing an ORR of 45% at the 12 µg/kg dose level. The company also announced that these results, along with data for velinotamig, will be presented at the 68th ASH Annual Meeting in December 2026. The data demonstrated that a two step-up dosing regimen improved safety by reducing the incidence and severity of cytokine release syndrome.

9:17 AM ET 10-Q
Financial Results Riot Platforms, Inc. RIOT ▶ Call

Riot Platforms Q3 2026 Results: Net Income $4.03M, Down 96.1% YoY

Riot Platforms reported total revenue of $181.4 million for the quarter ended September 30, 2026, reflecting a strategic shift toward Data Center and Engineering services despite a decline in Bitcoin Mining revenue. The company's balance sheet shows a significant reduction in Bitcoin holdings from $1.23 billion to $202 million and an accumulated deficit of $2.09 billion.

Key figure
Net income $4.03M · -96.1% YoY
9:16 AM ET 10-Q
Financial Results Reynolds Consumer Products Inc. REYN

Reynolds Consumer Products Q3 2026 Results: Net Income $58M, Down 26.6% YoY

Reynolds Consumer Products reported total net revenues of $944 million for the quarter ended September 30, 2026, a slight increase from $931 million in the prior year. Net income for the quarter decreased to $58 million compared to $79 million in 2025, primarily driven by higher selling, general and administrative expenses and other net expenses.

Key figure
Net income $58M · -26.6% YoY
9:15 AM ET 10-Q
Financial Results Neostellar Capital Corp. NSLR

Neostellar Capital Q3 2026 Results: Net Loss of $21.2M

Neostellar Capital Corp. reported a net change in net assets resulting from operations of $115.8 million for the nine months ended September 30, 2026, driven primarily by $148.9 million in net unrealized appreciation. However, the company experienced a significant net investment loss of $31.4 million during the same period, largely due to a sharp increase in compensation and operating expenses.

Key figure
Net loss $21.2M
9:14 AM ET 10-Q
Financial Results FTC Solar, Inc. FTCI

FTC Solar Q3 2027 Results

FTC Solar reported total revenue of $32.8 million for the third quarter of 2026, a 26% increase year-over-year, and achieved a net income of $6.7 million compared to a net loss in the prior year period. This profitability was primarily driven by a $19.5 million gain from the change in fair value of warrant liabilities, which offset an operating loss of $8.5 million.

9:14 AM ET 10-Q
Financial Results Circle Internet Group, Inc. CRCL

Circle Internet Group Q3 2026 Results: Net Income $226M, Up 5.4% YoY

Circle Internet Group reported a significant reduction in its accumulated deficit from $1.29 billion at year-end 2025 to $963.2 million as of September 30, 2026, indicating profitable operations during the period. The company maintains a massive balance sheet with $77.7 billion in total assets, primarily driven by $73.5 billion in cash and equivalents held for the benefit of stablecoin holders.

Key figure
Net income $226M · +5.4% YoY
9:13 AM ET 8-K
Financial Results UWM Holdings Corp UWMC

UWM Holdings Financial Results

UWM Holdings Corp reported Q3 2026 financial results with net income of $212.6 million on total revenue of $811.1 million. Loan origination volume reached $33.4 billion, driven by $22.8 billion in purchase originations, despite a higher interest rate environment.

Term
Q3 2026

“Our third quarter results show the strength of UWM and our ability to perform in any market. Even with rates staying higher, our origination engine, operational execution and service levels continue to set us apart. At the same time, the investments we’re making in artificial intelligence and technology are driving greater efficiencies across the business and helping lower expenses.”

Mat Ishbia, Chairman, Chief Executive Officer and President
9:11 AM ET 8-K
Loan & Debt AeroVironment Inc AVAV

AeroVironment $450M Debt Financing with Bank of America, N.A.

AeroVironment entered into a Sixth Amendment to its existing credit agreement, increasing its aggregate revolving commitments by $100 million to a new total of $450 million. The amendment also reallocates commitments among lenders, adds BMO Bank N.A. as a new lender, and maintains the maturity date of October 4, 2029. This follows a recent Fifth Amendment that increased the letter of credit sublimit to $150 million.

Value
$450M
Counterparty
Bank of America, N.A.
Term
through Oct 2029
9:10 AM ET 8-K
Divestiture Penguin Solutions, Inc. PENG

Penguin Solutions Divestiture to Transom Capital Group, LLC

Penguin Solutions has entered into a definitive agreement to sell its Cree LED business (Optimized LED segment) to Transom Capital Group in an all-cash transaction. The divestiture is part of the company's strategy to transform into a pure-play data center AI infrastructure solutions provider. The deal is expected to close in the first calendar quarter of 2027, subject to customary closing conditions.

Counterparty
Transom Capital Group, LLC
9:08 AM ET 10-Q
Financial Results Charles River Laboratories International, Inc. CRL

Charles River Laboratories International Q3 2026 Results: Net Income $333M, Up 512.0% YoY

For the three months ended September 26, 2026, Charles River Laboratories reported total revenue of $982.7 million, a slight decrease from $1.00 billion in the prior year. Despite the revenue dip, net income attributable to common shareholders rose significantly to $333.1 million, primarily driven by a substantial income tax benefit of $163.8 million.

Key figure
Net income $333M · +512.0% YoY
9:08 AM ET 10-Q
Financial Results Royalty Pharma plc RPRX ▶ Call

Royalty Pharma Q3 2026 Results: Net Income $145M, Down 49.1% YoY

Royalty Pharma reported total income and other revenues of $1.99 billion for the first nine months of 2026, up from $1.76 billion in the prior year period. Despite the revenue growth, consolidated net income for the nine-month period decreased to $816.4 million from $967.3 million, primarily due to higher interest expenses and a $219.8 million impairment on financial royalty assets.

Key figure
Net income $145M · -49.1% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.